Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19375
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParker, Lewan-
dc.contributor.authorLin, Xuzhu-
dc.contributor.authorGarnham, Andrew-
dc.contributor.authorMcConell, Glenn-
dc.contributor.authorStepto, Nigel K-
dc.contributor.authorHare, David L-
dc.contributor.authorByrnes, Elizabeth-
dc.contributor.authorEbeling, Peter R-
dc.contributor.authorSeeman, Ego-
dc.contributor.authorBrennan-Speranza, Tara C-
dc.contributor.authorLevinger, Itamar-
dc.date2018-08-23-
dc.date.accessioned2018-09-17T01:47:03Z-
dc.date.available2018-09-17T01:47:03Z-
dc.date.issued2019-
dc.identifier.citationJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research 2019; 34(1): 49-58en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/19375-
dc.description.abstractIn mice, glucocorticoid-induced insulin resistance occurs largely through impaired osteoblast function and decreased circulating undercarboxylated osteocalcin (ucOC). Whether these mechanisms contribute to glucocorticoid-induced insulin resistance in humans has yet to be established. In addition, the effects of glucocorticoids on the exercise-induced increase in circulating ucOC and insulin sensitivity are also unknown. We hypothesized that acute glucocorticoid treatment would lead to basal and post-exercise insulin resistance in part through decreased circulating ucOC and ucOC-mediated skeletal muscle protein signaling. Nine healthy males completed two separate cycling sessions 12 hours after ingesting either glucocorticoid (20 mg prednisolone) or placebo (20 mg Avicel). The homeostatic model assessment was used to assess basal insulin sensitivity and a 2-hour euglycemic-hyperinsulinemic clamp was commenced 3 hours after exercise to assess post-exercise insulin sensitivity. Serum ucOC and skeletal muscle protein signaling were measured. Single-dose glucocorticoid ingestion increased fasting glucose (27%, p < 0.01) and insulin (83%, p < 0.01), and decreased basal insulin sensitivity (-47%, p < 0.01). Glucocorticoids reduced insulin sensitivity after cycling exercise (-34%, p < 0.01), reduced muscle GPRC6A protein content (16%, p < 0.05), and attenuated protein phosphorylation of mTORSer2481 , AktSer374 and AS160Thr642 (59%, 61% and 50%, respectively; all p < 0.05). Serum ucOC decreased (-24%, p < 0.01) which correlated with lower basal insulin sensitivity (r = 0.54, p = 0.02), lower insulin sensitivity after exercise (r = 0.72, p < 0.05), and attenuated muscle protein signaling (r = 0.48-0.71, p < 0.05). Glucocorticoids -induced basal and post-exercise insulin resistance in humans is associated with the suppression of circulating ucOC and ucOC-linked protein signaling in skeletal muscle. Whether ucOC treatment can offset Glucocorticoids -induced insulin resistance in human subjects requires further investigation This article is protected by copyright. All rights reserved.en_US
dc.language.isoeng-
dc.subjectAnti-inflammationen_US
dc.subjectGlucocorticoid Metabolismen_US
dc.subjectGlycemic Controlen_US
dc.subjectHigh-intensity Interval Exerciseen_US
dc.subjectInsulin Signalingen_US
dc.titleGlucocorticoid-induced insulin resistance in men is associated with suppressed undercarboxylated osteocalcin.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Researchen_US
dc.identifier.affiliationDepartment of Physiology, University of Sydney, Sydney, NSW, Australiaen_US
dc.identifier.affiliationMary Mackillop Institute of Health Research, Australian Catholic University, Melbourne, VIC, Australiaen_US
dc.identifier.affiliationInstitute for Physical Activity and Nutrition (IPAN), Deakin University, Geelong, VIC, Australiaen_US
dc.identifier.affiliationInstitute of Health and Sport (IHES), Victoria University, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationAustralian Institute for Musculoskeletal Science (AIMSS), Department of Medicine-Western Health, Melbourne Medical School, The University of Melbourne, Melbourne, VIC, Australiaen_US
dc.identifier.affiliationMonash Centre of Health Research and Implementation (MCHRI), School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australiaen_US
dc.identifier.affiliationUniversity of Melbourne, Melbourne, VIC, Australiaen_US
dc.identifier.affiliationPathWest QEII Medical Centre, Perth, WA, Australiaen_US
dc.identifier.affiliationDepartment of Medicine, School of Clinical Sciences, Monash University, Melbourne, VIC, Australiaen_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.doi10.1002/jbmr.3574en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-9692-048Xen_US
dc.identifier.orcid0000-0001-9554-6556en_US
dc.identifier.pubmedid30138543-
dc.type.austinJournal Article-
local.name.researcherHare, David L
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptCardiology-
crisitem.author.deptEndocrinology-
crisitem.author.deptCardiology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

66
checked on Dec 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.